Kabamba Kabeya

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Gilles Darcis, Anna Kula, Sophie Bouchat et al. · PLoS Pathogens · 2015 · 279 citations · Full text

Latency-reversing Agent Combinations, Immunology, Hiv-1 Eradication +22

Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection

S. Reuse, Miriam Calao, Kabamba Kabeya et al. · PLoS ONE · 2009 · 238 citations · Full text

Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients

Sophie Bouchat, Jean-Stéphane Gatot, Kabamba Kabeya et al. · AIDS · 2012 · 145 citations · Full text

Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140)

W. Garrett Nichols, H. M. Steel, Tab Bonny et al. · Antimicrobial Agents and Chemotherapy · 2007 · 145 citations

Immunology, Apl Plasma Exposures, Pharmacotherapy +21

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates <scp>HIV</scp> ‐1

Sophie Bouchat, Nadège Delacourt, Anna Kula et al. · EMBO Molecular Medicine · 2015 · 84 citations · Full text